These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Pharmacokinetics and pharmacodynamics of antimicrobial therapy used in child osteoarticular infections]. Cohen R; Grimprel E Arch Pediatr; 2007 Oct; 14 Suppl 2():S122-7. PubMed ID: 17956820 [TBL] [Abstract][Full Text] [Related]
5. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections. Appelbaum PC Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544 [TBL] [Abstract][Full Text] [Related]
6. The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints. Stass H; Dalhoff A Infection; 2005 Dec; 33 Suppl 2():29-35. PubMed ID: 16518709 [TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance and the need for the rational use of antibiotics. Hueston WJ; Dickerson L J Med Liban; 2001; 49(5):246-56. PubMed ID: 12243418 [TBL] [Abstract][Full Text] [Related]
8. [Blood and respiratory diffusion of antibiotics. A critical analysis of predictive parameters for clinical effectiveness]. Fantin B Med Mal Infect; 2006; 36(11-12):599-613. PubMed ID: 16837154 [TBL] [Abstract][Full Text] [Related]
9. [Bacterial resistance and pharmacodynamics as the basis for prescribing antibiotics in respiratory infections]. Aguado-García JM; Martín-Herrero JE; Lumbreras-Bermejo C Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):230-7. PubMed ID: 15056440 [TBL] [Abstract][Full Text] [Related]
10. Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus. Fritsche TR; Jones RN J Drugs Dermatol; 2005; 4(6 Suppl):s4-8. PubMed ID: 16300223 [TBL] [Abstract][Full Text] [Related]
11. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections. Andes D; Anon J; Jacobs MR; Craig WA Clin Lab Med; 2004 Jun; 24(2):477-502. PubMed ID: 15177850 [TBL] [Abstract][Full Text] [Related]
12. [Osteoarticular infections: therapeutic proposals of the Paediatric Infectious Diseases Group of the French Society of Paediatrics (GPIP)]. Grimprel E; Lorrot M; Haas H; Pinquier D; Parez N; Ferroni A; Cohen R; Arch Pediatr; 2008 Oct; 15 Suppl 2():S74-80. PubMed ID: 19000859 [TBL] [Abstract][Full Text] [Related]
13. [Nosopharyngeal microflora in ambulatory treated children and adults with upper respiratory tract infections]. Zientara M; Rudy M; Nowakowska M; Martirosian G Med Dosw Mikrobiol; 2006; 58(3):239-45. PubMed ID: 17340999 [TBL] [Abstract][Full Text] [Related]
17. [Microbiological causes of antibiotic therapy failure in respiratory tract infections]. Kozioł-Montewka M Pol Merkur Lekarski; 2011 May; 30(179):373-6. PubMed ID: 21675146 [TBL] [Abstract][Full Text] [Related]
18. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus. Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore. Ambrose PG; Bhavnani SM; Rubino CM; Louie A; Gumbo T; Forrest A; Drusano GL Clin Infect Dis; 2007 Jan; 44(1):79-86. PubMed ID: 17143821 [TBL] [Abstract][Full Text] [Related]
20. Part II. Introduction to the beta-lactam antibiotics. Cooper TW; Gibbs WJ; Bronze MS; Greenfield RA J Okla State Med Assoc; 2006 Oct; 99(10):516-20. PubMed ID: 17125105 [No Abstract] [Full Text] [Related] [Next] [New Search]